•
BN
BNTX
BioNTech SE American Depositary Share
polygon--
Price Chart
Market Cap
29.61B
Volume
77.52K
52W High
$126.77
52W Low
$81.20
Open
$119.41
Prev Close
$118.00
Day Range
119.30 - 119.79
About BioNTech SE American Depositary Share
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Latest News
Nanobiotechnology Market to Hit USD 420.2 Billion by 2034, Fueled by 2025 Traffic Growth and Strategic Material & Product Innovations
GlobeNewswire Inc.•Dec 17
Pfizer Sees Slower 2026 Growth Despite Pipeline Push, Cost Cuts
Benzinga•Dec 16
BioNTech-Bristol Drug Shows Hope For Breast Cancer Patients With Few Options
Benzinga•Dec 9
BioNTechs und OncoC4s selektiver Treg-Modulatorkandidat Gotistobart erzielte klinisch relevanten Gesamtüberlebensvorteil bei Patientinnen und Patienten mit zuvor behandeltem Plattenepithelkarzinom der Lunge
GlobeNewswire Inc.•Dec 6
BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
GlobeNewswire Inc.•Dec 6
BioNTech Achieves Minimum Condition in CureVac Exchange Offer
Benzinga•Dec 3
2 Top Dividend Stocks to Buy and Hold
The Motley Fool•Nov 30
Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035
GlobeNewswire Inc.•Nov 27